NBRV
Nabriva Therapeutics plc
Set alert
1.42 0.00 0.00%
1.35 Day range 1.90
52-week range unavailable
- Open
- 1.45
- Prev close
- 1.42
- Mkt cap
- 4.96M
- Vol
- 706.54K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.35
- High
- 1.90
- Forward P/E
- -0.18
- Beta
- 1.55
- Short ratio
- 6.12
- Inst. own
- 9.21%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 2, 2023
- 50-d avg
- 1.57
- 200-d avg
- 1.83
- 1y target
- 0.00
Ownership
Held by insiders 0.43%
Held by institutions 9.21%
Float held by institutions 9.25%
Institutions 17
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Values First Advisors, Inc. | 0.83% | 26,682 | 41.36K | Mar 30, 2023 |
| Renaissance Technologies, LLC | 0.73% | 23,361 | 36.21K | Mar 30, 2023 |
| Frazier Life Sciences Management, L.P. | 0.53% | 17,025 | 26.39K | Mar 30, 2023 |
| Citadel Advisors Llc | 0.36% | 11,607 | 17.99K | Mar 30, 2023 |
| Morgan Stanley | 0.13% | 4,108 | 6.37K | Mar 30, 2023 |
| Advisor Group Holdings, Inc. | 0.06% | 2,008 | 3.11K | Mar 30, 2023 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.05% | 1,709 | 2.65K | Feb 27, 2023 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BROOM COLIN | Director | Sale | Aug 1, 2022 | 36,523 |
| BURGESS DANIEL D | Director | Sale | Aug 1, 2022 | 10,384 |
| CORRIGAN MARK | Director | Sale | Aug 1, 2022 | 7,203 |
| DOLAN DANIEL | Chief Financial Officer | Conversion of Exercise of derivative security | Aug 10, 2022 | 0 |
| GELONE STEVEN P | President | Conversion of Exercise of derivative security | Aug 10, 2022 | 0 |
| GUICO-PABIA CHRISTINE J | Officer | Conversion of Exercise of derivative security | Aug 10, 2022 | 0 |